Updated:
CARMA FUND Management
CARMA FUND Management GmbH was established to operate CARMA FUND I. The vehicle concentrates exclusively on early-stage life science and healthcare...
Overview
CARMA FUND Management GmbH was established to operate CARMA FUND I. The vehicle concentrates exclusively on early-stage life science and healthcare investments. The strategy centers on seed and early-stage commitments in therapeutics, diagnostics, MedTech, digital health, R&D tools, and platform technologies. Capital supports preclinical work, product development, and market entry. Confirmed geographic scope covers Europe. No specific portfolio companies or co-investors appear in available records. Team size, additional offices, and adjacent vehicles remain undisclosed. No operational events from the last 24 months are recorded. The firm maintains a single-fund structure tied directly to its stated 15-year investment horizon and technology-transfer sourcing model.
General information
Firm type
Private Equity
Year founded
2022
AUM
€56M
Location
Region
Europe
Country
Germany
City
Munich
Corporate office
Munich, Germany
Sector focus
Frequently asked questions
What stages does CARMA FUND Management target?
The firm targets seed and early-stage investments in life science and healthcare companies.
Which sectors receive capital from CARMA FUND I?
Allocations focus on therapeutics, diagnostics, MedTech, digital health, R&D tools, and platform technologies.
Where does CARMA FUND Management source opportunities?
Opportunities originate from technology transfer offices and industry partners across Europe.
What is the investment horizon for CARMA FUND I?
The fund operates over a 15-year-plus horizon to support development through market entry.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: